Radar Tires Thinks Pink

NEW YORK--Aug. 10, 2011: Omni United, one of the fastest growing and most dynamic designers and manufacturers of tires in the world, has announced Radar's plans to launch a limited-edition pink walled tire in support of 'Mobilizing Hope' -- the flagship brand's groundbreaking year-long partnership with The Breast Cancer Research Foundation (BCRF).

Through its "Mobilizing Hope campaign, launched in the United States and other top markets in May 2011, Radar donates $.25 for every Radar tire sold, with a committed minimum annual donation to BCRF of $250,000. Radar's first product specifically designed to support this campaign will be a limited edition of its well known RPX900 tire, an all season, high performance, eco-friendly tire that features an asymmetrical tread design ideal for mid to high performance vehicles. The Limited Edition, in addition to all the features of the RPX900, has the novelty of a pink sidewall, highlighting the emblematic pink color of the fight against breast cancer cause globally. The tire will have a retail price in the range of $70-$110 and is expected to be available starting in the last quarter of 2011 at leading tire retailers carrying the Radar brand in the US.

"This is a more visible way to support our Mobilizing Hope campaign to benefit the activities of BCRF," said Mr. G.S. Sareen, President and CEO of Omni United, parent company of Radar Tires. "We are delighted to be able to develop this limited edition of one of our best selling tires, the RPX900, to reinforce our commitment to supporting breast cancer research."

About Omni / Radar

Radar Tires is the flagship tire brand of Omni United, offering a complete range of passenger car, SUV, truck, bus, and farm tires, marketed under its own four brand names: Radar, Goodride, Roadlux and Corsa. Besides designing and manufacturing tires, Omni's unparalleled customer service and its state-of-the-art logistics and supply chain management systems are a cornerstone of its success.

About The Breast Cancer Research Foundation®

The Breast Cancer Research Foundation® was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit organization dedicated to funding innovative clinical and translational research at leading medical centers worldwide. In October 2010, BCRF awarded $33 million to 172 scientists across the United States, Canada, Latin America, Europe, the Middle East, and Australia. Currently, more than 90 cents of every dollar donated is directed to breast cancer research and awareness programs. With exceptionally low administrative costs, BCRF continues to be one of the most efficient organizations in the USA. BCRF has received 4 stars from Charity Navigator for nine consecutive years, outperforming 99% of more than 5,500 evaluated charities. Furthermore, the Foundation is consistently listed as an "A+" charity by The American Institute of Philanthropy. BCRF is the only breast cancer organization to receive AIP's top accolade, and is currently the only cancer organization to hold this ranking.